Neuromodulators, such as substance P (SubP), play an important role in modulating many rhythmic activities driven by central pattern generators (e.g. locomotion, respiration). However, the mechanism by which SubP enhances breathing regularity has not been determined. Here, we used mouse brainstem slices containing the pre-Bö tzinger complex to demonstrate, for the first time, that SubP activates transient receptor protein canonical (TRPC) channels to enhance respiratory rhythm regularity. Moreover, SubP enhancement of network regularity is accomplished via selective enhancement of ICAN (inward non-specific cation current)-dependent intrinsic bursting properties. In contrast to INaP (persistent sodium current)-dependent pacemakers, ICAN-dependent pacemaker bursting activity is TRPC-dependent. Western Blots reveal TRPC3 and TRPC7 channels are expressed in rhythmically active ventral respiratory group island preparations. Taken together, these data suggest that SubP-mediated activation of TRPC3 ⁄ 7 channels underlies rhythmic ICAN-dependent pacemaker activity and enhances the regularity of respiratory rhythm activity.
Introduction
Neural networks termed central pattern generators underlie rhythmic motor activities such as gut peristalsis, locomotion and breathing (Smith et al., 1991; Grillner, 2006) . Synaptic and intrinsic membrane conductances are continuously modulated by excitatory and inhibitory inputs coming from different regions of the brain (Barthe & Clarac, 1997; Thoby-Brisson & Simmers, 1998; Gray et al., 1999; Feldman et al., 2001; Kozlov et al., 2001; Jun et al., 2004; Pearlstein et al., 2005; Tryba et al., 2006; Saideman et al., 2007; Boesmans et al., 2008; Chevalier et al., 2008) , providing an important plasticity to the network. In mammals, the pre-Bötzinger complex (pre-BötC) located within the medullary ventral respiratory group (VRG) is critical for generating the inspiratory rhythm activity (Gray et al., 1999; Wenninger et al., 2004; McKay et al., 2005) . This rhythm depends on both a non-specific cation current (ICAN) and persistent sodium current (INaP) (Thoby-Brisson & Ramirez, 2001; Peña et al., 2004; Pace et al., 2007) . The pre-BötC can be isolated in vitro, and generates three forms of the respiratory pattern, namely fictive eupnea, sighs and gasping (during hypoxic conditions) (Lieske et al., 2000) . These three patterns are strongly influenced by neuromodulators (Lieske et al., 2000; Ruangkittisakul et al., 2008; Tryba et al., 2008) .
Because of the important role of neuromodulators, a disturbance in the neuromodulatory system may lead to breathing disorders such as Rett syndrome or suddent infant death syndrome (SIDS). In these cases, respiratory irregularities are associated with a deficiency in numerous neuromodulators, such as serotonin, dopamine, noradrenaline and substance P (SubP) (Lekman et al., 1989; Zoghbi et al., 1989; Matsuishi et al., 1997; Segawa, 1997; Deguchi et al., 2000; Viemari et al., 2005) .
Here we focused on the excitatory effects of SubP on respiratory rhythm activity. SubP activates neurokinin-1 (NK1) receptors (Gray et al., 1999) that are positively coupled to G q ⁄ 11-proteins that are pertussis toxin-insensitive and will activate phospholipase C (PLC), leading to the production of diacylglycerol and inositol triphosphate and activation of protein kinase C. This intracellular pathway is known to induce a cation current. However, the nature of the channels opened by SubP is not yet known.
Here we propose that SubP activates transient receptor protein canonical channels (TRPCs) to improve the regularity of respiratory rhythmic activity. TRPCs are non-selective cation channels that are permeable to monovalent and divalent ions (Clapham, 2003) . Some of the TRPCs are activated by the inositol phospholipid hydrolysis system. Also, the SubP receptor can be functionally linked to TRPC3 channels (Oh et al., 2003) . Our results reveal that SubP activates TRPC3 and ⁄ or TRPC7 (TRPC3 ⁄ 7) channels that underlie rhythmic ICAN-dependent pacemaker activity and enhance the regularity of the respiratory rhythm.
Materials and methods
All experiments conformed to the guiding principles for the care and use of animals approved by the National Institutes of Health and the Internal Animal Care and Use Committee at the Medical College of Wisconsin.
Respiratory medullary brain-slice preparation
All experiments used transverse, rhythmic 600-lm-thick medullary brain slices obtained from 8-to 11-day-old, CD-1 outbred mice (Charles River Laboratories, Wilmington, MA, USA; Smith et al., 1991) . CD-1 mice were quickly decapitated at the C3 ⁄ C4 spinal level and the brainstem was dissected in ice-cold artificial cerebral spinal fluid (ACSF) equilibrated with carbogen (95% O 2 and 5% CO 2 , pH = 7.4). Rhythmic medullary brainslice preparations (600 lm thick) containing the VRG, including the pre-BötC, were obtained by slicing the medulla using a microslicer (Leica VT1000S; Leica, Nussloch, Germany) as described in detail elsewhere (Thoby-Brisson & Ramirez, 2001; Chevalier et al., 2008) . Slices were submerged in a recording chamber (6 mL) under circulating ACSF (30°C; flow rate 17 mL ⁄ min, total circulating volume = 200mL).
The ACSF contained (mm): 118 NaCl, 3 KCl, 1.5 CaCl 2 , 1 MgCl 2 .6H 2 O, 25 NaHCO 3 , 1 NaH 2 PO 4 and 30 d-glucose, equilibrated with carbogen (95% O 2 and 5% CO 2 , pH = 7.4). All ACSF chemicals were obtained from Sigma (St Louis, MO, USA). Extracellular KCl was elevated from 3 to 8 mm over a span of 30 min before commencing recordings to maintain rhythmic population activity (Tryba et al., 2003) (Tryba et al., 2003) . Furthermore, it should be noted that [K + ] o changes on a breath by breath basis, although these changes in [K + ] o do not obviously alter the form of respiratory activity generated, as both eupneic and gasping activities can be recorded in hypokalemic and hyperkalemic conditions in situ (St.-John et al., 2005) . As bath temperature can alter respiratory slice activity (Tryba & Ramirez, 2004a) , bath temperature was monitored and maintained at 30 ± 0.7°C using a Warner Instrument Corp. (Hamden, CT, USA) TC-344B temperature regulator with an in-line solution heater (SH-27B); bath temperature at various locations within the bath was uniform.
Western blots of VRG islands containing the pre-BötC
In order to determine the expression of TRP channels and NK1 receptors in the VRG, we prepared rhythmic 600-lm-thick VRGisland preparations (Johnson et al., 2001) containing the pre-BötC by taking a brain slice preparation (above) and cutting a wedge-shaped piece of tissue containing the pre-BötC out of the transverse brain slice using a sharp scalpel blade . The extent of the VRG-island ⁄ pre-BötC to be removed was determined by delineating the VRG borders with population electrode mapping on the surface of the slice prior to cutting out the VRG-island. We also isolated the cortex and cerebellum, as a positive control for TRP channel expression. Tissues were homogenized in 10 mm potassium phosphate buffer (pH 7.7), containing complete mini protease inhibitor (0.36 mg ⁄ mL) (400; Roche, Indianapolis, IN, USA) added at time of use. The homogenates were centrifuged at 2000 g for 15 min at 4°C. Protein concentrations in the supernatant were determined using a DC protein assay (Bio-Rad Labs, Hercules, CA, USA). Proteins were loaded at 10, 15 or 50 lg in each well and separated by electrophoresis on a 10% Tris-HCl Ready Gel (Bio-Rad Labs) at 100 V under denaturing conditions. Proteins were then transferred to a nitrocellulose membrane (Bio-Rad Labs). The membranes were blocked overnight at 4°C with 5% non-fat dried milk (Bio-Rad Labs) and 1% albumin from bovine serum (Sigma) in Tris-buffered saline (pH 7.5) containing 0.1% Tween-20 (TBS-T) and immunoblotted for 2 h at room temperature with either anti-NK1 antibody (1 : 10 000; Invitrogen, Van Allen Way Carlsbad, CA, USA), anti-TRPC1 antibody (1 : 500; Alomone Labs, Jerusalem, Israel), anti-TRPC3 antibody (1 : 500; Alomone Labs), anti-TRPC4 antibody (1 : 100; Alomone Labs), anti-TRPC5 antibody (1 : 300; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-TRPC6 antibody (1 : 400; Alomone Labs), anti-TRPC7 antibody (1 : 300; Millipore, Billerica, MA, USA), anti-TRPM4 antibody (1 : 1000; Abcam, Cambridge, MA, USA) in 2% NFDM in TBS-T or anti-GAPDH (1 : 300; Abcam) used as a loading control. The secondary antibody, goat anti-rabbit-HRP (1 : 10 000; Santa Cruz) was incubated for 1h at room temperature. Membranes were developed using enhanced chemiluminescence (Pierce ECL-West Pico kit; Thermo Fisher Scientific, Pittsburgh, PA, USA) on X-ray film (Phenix Research Products, Candler, NC, USA).
Electrophysiology: population activity and identification of inspiratory neurons
Extracellular recordings were obtained with glass suction electrodes positioned on the slice surface in the VRG near or on top of the preBötC ( Fig. 1A and B) . The VRG population bursting is dominated by inspiratory neurons such that integrated VRG (òVRG) activity is inphase with integrated XII (òXII) activity (Tryba et al., 2006; Chevalier et al., 2008) . Thus, VRG population bursts serve as a marker of fictive inspiration (Tryba et al., 2006; Chevalier et al., 2008) . This population activity was rectified and integrated and the data were digitized with a Digidata acquisition system (Molecular Devices, Sunnyvale, CA, USA), stored on an IBM-compatible PC using Axoscope 10 (Molecular Devices) software and analysed off-line using Igor Pro (WaveMetrics, Lake Oswego, OR, USA). Intracellular whole-cell current-clamp recordings were obtained with a MultiClamp 700B amplifier (Molecular Devices), applying the blind-patch technique to VRG neurons in brainstem slice preparations (Thoby-Brisson & Ramirez, 2001) . Patch electrodes were manufactured from filamented borosilicate glass tubes (Clark G150F-4; Warner Instruments Corp., Hamden, CT, USA) and filled with an intracellular solution containing (in mm): 140 K-gluconic acid, 1 CaCl 2 .6H 2 O, 10 EGTA, 2 MgCl 2 .6H 2 O, 4 Na 2 ATP and 10 HEPES.
Only inspiratory VRG neurons active in-phase with the òVRG population burst were recorded in this current-clamp study (Fig. 1B) . The discharge pattern of each cell type was first identified in the cellattached mode and remained similar in whole-cell configuration (Peña et al., 2004; Tryba et al., 2008) . Experiments were then performed in the whole-cell patch-clamp mode. Membrane voltage (V m ) values were corrected for the liquid junction potential as calculated using pClamp 10 software (Molecular Devices). In current-clamp mode, neurons were isolated from ionotropic chemical synaptic input using a mixture of glutamatergic, GABAergic and glycinergic antagonists. These drugs were bath applied at final concentrations of: 20 lm 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris Biosciences, Ellisville MO, USA), 10 lm (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (RS-CPP; Tocris Biosciences), 1 lM strychnine (Sigma) and 20 lm bicuculline free-base (Sigma Aldrich). Note that unlike bicuculline methiodide, the bicuculline free base derivative is a specific GABA receptor antagonist that does not block apaminsensitive Ca 2+ -activated K + currents. SubP (Sigma) was bath-applied at 0.1 lm, SKF-96365 hydrochloride (Tocris Biosciences) at 5-10 lm, flufenamic acid (FFA) at 50 lm and riluzole (Sigma) at 10 lm.
A subset of neurons, considered inspiratory pacemakers, continued to generate voltage-dependent intrinsic bursting properties following blockade of ionotropic glutamate (both AMPAR and NMDAR antagonists were co-applied) and after blocking GABA and glycinergic receptors (Peña et al., 2004) . These pacemakers met several criteria before being classified as inspiratory pacemaker neurons; the criteria used here are provided in detail elsewhere (Thoby-Brisson & Ramirez, 2001; Tryba et al., 2003) . In control conditions, in contrast to non-pacemakers, brief depolarizing current injection could evoke an additional cellular burst that was ectopic relative to òVRG population bursts. Unlike pacemakers, hyperpolarization of non-pacemakers below threshold caused non-pacemakers to cease bursting (Tryba et al., 2003) . After isolation of the neuron from fast chemical synaptic input with bath-applied CNQX, RS-CPP, strychnine and bicuculline, pacemakers continued to burst in the absence of òVRG population bursts. Second, isolated pacemakers exhibited voltage-dependent bursting properties. That is, brief depolarizing current injection could evoke a burst, or hyperpolarizing current could terminate an ongoing burst; either of these reset the ongoing pacemaker bursting rhythm. Finally, depolarizing current injection increased, and injected hyperpolarizing current injection decreased, the bursting frequency.
Data analysis
To measure òVRG network or pacemaker bursting regularity, we calculated an irregularity score (S), by applying a formula for consecutive cycle length values: S n = 100 · ABS(P n -P n-1 ) ⁄ P n-1 , where S n is the score of the nth cycle, P n is its period, P n-1 is the period of the preceding burst and ABS the absolute value (Barthe & Clarac, 1997; Telgkamp et al., 2002; Viemari et al., 2005; Chevalier et al., 2008) . Regular rhythms have lower irregularity scores whereas irregular rhythms have higher irregularity scores (Telgkamp et al., 2002; Chevalier et al., 2008) . For comparison, we calculated the irregularity score of the òVRG and inspiratory neurons (over a period of 5 min) and isolated pacemaker rhythmic bursts (over a period of 2 min) in control and following experimental manipulation. The burst area was measured as the area between the baseline and the burst envelope, while frequency was calculated based on the burst peak intervals. To minimize the potential influence of baseline fluctuations and differences in burst peak trajectories, the burst duration was calculated as the duration of the burst at half-maximal burst amplitude.
Data were analysed off-line with ClampFit 9.2 (Molecular Devices) and Igor Pro (WaveMetrics) and further statistical analysis was performed with Graph Pad Prism software v4.03 (San Diego, CA, USA). A paired Student's t-test was used to compare raw data obtained from a given specimen in two different conditions. Regularity measures and burst areas are measured in arbitrary units throughout. Results are given in the text in the form of mean ± SEM and in the figures the data are represented in the form of the percentage of control (significance was assumed at P = 0.05).
Results

Mechanisms underlying SubP modulation of eupneic activity
TRPC channel antagonists blocked SubP-mediated enhancement of fictive eupnea
SubP enhances the regularity of fictive eupneic activity in vitro (Telgkamp et al., 2002; Pena & Ramirez, 2004) , although the underlying mechanism is unknown. SubP has been shown to activate TRPC3 channels in HEK293 cells, leading to an ICAN (Oh et al., 2003) . We tested the hypothesis that SubP enhances fictive eupneic regularity and bursting properties via TRPC channel activation using the respiratory medullary brain slice preparation, containing the preBötC. We bath-applied 0.1 lm SubP for 20 min, evoking a decrease in fictive eupnea irregularity (0.35 ± 0.05 and 0.17 ± 0.01, before and after SubP, respectively, n = 20 slice preparations, P < 0.001, paired t-test), enhancement of òVRG burst area (0.09 ± 0.02 and 0.17 ± 0.07, before and after SubP, respectively, n = 20 slice preparations, P < 0.05, paired t-test) and increase in burst frequency (0.21 ± 0.02 and 0.36 ± 0.02 Hz, before and after SubP, respectively, n = 20 slice preparations, P = 0.001, paired t-test) without altering burst duration (0.51 ± 0.02 and 0.50 ± 0.03 s, before and after SubP, respectively, n = 20 slice preparations, P > 0.05, paired t-test) ( Fig. 2A1-2 and B). These data are consistent with previously published studies of SubP effects on respiratory activity (Gray et al., 1999; Shvarev et al., 2002; Pena & Ramirez, 2004) . After slices were exposed to SubP for 20 min, we co-applied a TRPC channel antagonist (Zhou et al., 2008) , SKF-96365. SubP-mediated enhancement of respiratory activity (Figs 2A1-2 and B, and 3A1-2) is reversed by subsequent bath-application of SKF-96365. òVRG burst irregularity increased (0.17 ± 0.02 and 0.30 ± 0.05, SubP and SubP + SKF-96365, respectively, n = 11 slice preparations, P < 0.05, paired t-test) whereas burst area (0.17 ± 0.05 and 0.11 ± 0.04, SubP and SubP + SKF-96365, respectively, n = 11 slice preparations, P < 0.01, paired t-test), burst duration (0.48 ± 0.03 and 0.41 ± 0.04 s, SubP and SubP + SKF-96365, respectively, n = 11 slice preparations, P < 0.01, paired t-test) and frequency were all decreased (0.39 ± 0.04 and 0.35 ± 0.06 Hz, SubP and SubP + SKF-96365, respectively, n = 11 slice preparations, P < 0.05, paired t-test) (Fig. 3A1-2 and B1-2). After bath-application of SKF-96365, additionally blocking INaP with riluzole completely abolished the òVRG respiratory rhythm ( Fig. 3C ; n = 11 slice preparations, in n = 11 ⁄ 11) whereby no rhythmic activity was recorded for > 17 min.
Whereas SubP enhanced fictive eupnea, subsequent bath-application of SKF-96365 effectively restored òVRG bursting regularity Substance P modulation of TRPC3 ⁄ 7 enhances respiratory rhythm regularity 1221 (0.31 ± 0.06 and 0.30 ± 0.05, before and after bath application of SubP + SKF-96365, respectively, n = 11 slice preparations, P > 0.05, paired t-test), burst area (0.07 ± 0.03 and 0.11 ± 0.04, before and after bath application of SubP + SKF-96365, respectively, n = 11 slice preparations, P > 0.05, paired t-test) and frequency (0.24 ± 0.04 and 0.35 ± 0.06 Hz, before and after bath application of SubP + SKF-96365, respectively, n = 11 slice preparations, P > 0.05, paired t-test) to control levels (ACSF alone), while burst duration (0.47 ± 0.03 and 0.41 ± 0.045 s, before and after bath application of SubP + SKF-96365, respectively, n = 11 slice preparations, P < 0.01, paired t-test) was reduced following SKF-96365 application (Fig. 3D) . Thus, SubPmediated modulation of TRPC channels plays a major role in altering fictive eupnea regularity.
ICAN antagonists blocked SubP-mediated enhancement of fictive eupnea
We tested the role of ICAN in SubP-mediated enhancement of fictive eupneic activity by blocking ICAN with FFA (50 lm), which in HEK293 cell lines was shown to block TRPC3 channels (Zhou et al., 2008) . After bath-applying SubP for 20 min, subsequent co-application of FFA increased òVRG burst irregularity (0.17 ± 0.02 and 0.45 ± 0.09, before and after perfusion of FFA, n = 6 slice preparations, P < 0.05, paired t-test) and decreased burst area (0.13 ± 0.04 and 0.04 ± 0.019, before and after perfusion of FFA, n = 6 slice preparations, P < 0.001, paired t-test), duration (0.54 ± 0.05 and 0.4 ± 0.04 s, before and after perfusion of FFA, n = 6 slice preparations, P < 0.01, paired t-test) and frequency (0.25 ± 0.03 and 0.14 ± 0.05 Hz, before and after perfusion of FFA, n = 6 slice preparations, P < 0.01, paired t-test) (Fig. 4A1-2 and B1-2) . Additionally applying riluzole completely abolished fictive eupneic rhythmic activity (òVRG) ( Fig. 4C ; n = 6 slice preparations; in n = 6 ⁄ 6, no rhythmic activity was recorded for > 17 min). Interestingly, the effects of FFA on the SubP response effectively restored òVRG burst irregularity (0.43 ± 0.13 and 0.45 ± 0.09, before and after perfusion of SubP + FFA, n = 6 slice preparations, P > 0.05, paired t-test), burst area (0.08 ± 0.04 and 0.04 ± 0.01, before and after perfusion of SubP + FFA, n = 6 slice preparations, P > 0.05, paired t-test) and burst frequency (0.55 ± 0.05 and 0.4 ± 0.04 Hz, before and after perfusion of SubP + FFA, n = 6 slice preparations, P > 0.05, paired t-test) to values similar to those observed in ACSF alone, while burst duration decreased (0.06 ± 0.03 and 0.14 ± 0.05 s, before and after perfusion of SubP + FFA, n = 6 slice preparations, P < 0.001, paired t-test) (Fig. 4D) . Together, these data demonstrate that the SubPmediated enhancement of fictive eupneic can be blocked by TRPC channel antagonists.
In additional experiments, we examined the role of endogenous TRPC channel activity by bath-applying 50 lm FFA (alone, in the absence of exogenous SubP) during fictive eupnea. Bath-application of FFA increased òVRG population bursting irregularity (0.26 ± 0.04 and 0.42 ± 0.08, before and after perfusion of FFA, n = 5 slice preparations, P < 0.01, paired t-test) and decreased burst area (0.04 ± 0.01 and 0.03 ± 0.004, before and after perfusion of FFA, n = 5 slice preparations, P < 0.05, paired t-test) and burst frequency (0.30 ± 0.04 and 0.21 ± 0.06 s, before and after perfusion of FFA, n = 5 slice preparations, P < 0.05, paired t-test) but does not alter burst duration (44 ± 0.02 and 0.31 ± 0.04 s, before and after perfusion of FFA, n = 5 slice preparations, P > 0.5, paired t-test) ( Fig. 5A1-2 ; and data not shown). In the presence of FFA, subsequent co-application of 0.1 lm SubP failed to decrease òVRG irregularity (0.42 ± 0.08 and 0.36 ± 0.07, in FFA and in FFA + SubP, respectively, n = 5 slice preparations, P > 0.05, paired t-test), burst area (0.03 ± 0.004 and 0.03 ± 0.003, in FFA and in FFA + SubP, respectively, n = 5 slice preparations, P > 0.05, paired t-test) and burst duration (0.31 ± 0.04 and 0.32 ± 0.04 s, in FFA and in FFA + SubP, respectively, n = 5 slice preparations, P > 0.05, paired t-test). However, network bursting frequency increased (0.21 ± 0.06 and 0.40 ± 0.06 Hz, in FFA and in FFA + SubP, respectively, n = 5 slice preparations, P > 0.05, paired t-test) (Fig. 5B1-2) , which may be due to SubP enhancement of other (non-TRPC channel-mediated) intrinsic and ⁄ or synaptic mechanisms, such as enhancement of NMDAR activity (Pena & Ramirez, 2004) . Subsequent co-application of riluzole eliminated the òVRG respiratory rhythm (n = 5 slice preparations, Fig. 5C ; in n = 5 ⁄ 5, no rhythmic activity was recorded for > 17 min). òVRG rhythmic activity during co-application of SubP and FFA remained more irregular (0.26 ± 0.04 and 0.36 ± 0.07, before and after perfusion of FFA + SubP, n = 5 slice preparations, P < 0.05, paired t-test), with a smaller burst area (0.04 ± 0.01 and 0.03 ± 0.03, before and after perfusion of FFA + SubP, n = 5 slice preparations, P < 0.01, paired t-test) than observed in ACSF alone, whereas burst duration (0.44 ± 0.02 and 0.32 ± 0.04 s, before and after perfusion of (B) SubP decreases the fictive eupneic, òVRG burst irregularity whereas it enhances the burst area and increases the burst frequency (*P < 0.05 and ***P < 0.001, paired t-test), without altering burst duration (statistical tests were made on raw data).
FFA + SubP, n = 5 slice preparations, P > 0.05, paired t-test) and frequency (0.30 ± 0.04 and 0.40 ± 0.06 Hz, before and after perfusion of FFA + SubP, n = 5 slice preparations, P > 0.05, paired t-test) were similar to control values (Fig. 5D ). These data demonstrate the importance of ICAN in SubP-mediated enhancement of fictive eupneic regularity.
Blocking INaP does not alter SubP-enhanced fictive eupneic regularity
To test whether blocking INaP prevents SubP effects on fictive eupnea, we first bath-applied 0.1 lm SubP for 20 min, evoking a decrease in fictive eupneic irregularity, enhancement of òVRG burst area and an increase in burst frequency, without altering burst duration . Subsequent bath application of riluzole did not alter the SubP-enhanced respiratory rhythm regularity (0.14 ± 0.02 and 0.16 ± 0.04, in SubP and in SubP + riluzole, n = 6 slice preparations, P > 0.05, paired t-test) or òVRG burst area (0.32 ± 0.17 and 0.24 ± 0.13, in SubP and in SubP + riluzole, n = 6 slice preparations, P > 0.05, paired t-test) (Fig. 6B1-2) , as observed after adding SKF-96365 or FFA (Fig. 5B2) . However, riluzole decreased òVRG burst duration (0.48 ± 0.05 and 0.41 ± 0.07 s, in SubP and in SubP + riluzole, n = 6 slice preparations, P < 0.05, paired t-test) and frequency (0.44 ± 0.03 and 0.40 ± 0.02 Hz, in SubP and in SubP + riluzole, n = 6 slice preparations, P < 0.01, paired t-test) (Fig. 6B2) .
Importantly, in the presence of SubP and riluzole, additionally co-applying SKF-96365 completely eliminated òVRG respiratory bursting ( Fig. 6C ; n = 6 slice preparations; in n = 6 ⁄ 6, no rhythmic activity was recorded for > 17 min). Rhythmic òVRG bursting during co-application of SubP and riluzole (alone) was more regular (0.27 ± 0.02 and 0.16 ± 0.04, before and after perfusion of SubP + riluzole, n = 6 slice preparations, P < 0.05, paired t-test) and had a higher frequency (0.23 ± 0.03 and 0.40 ± 0.02 Hz, before and after perfusion of SubP + riluzole, n = 6 slice preparations, P < 0.01, paired t-test) (Fig. 6B1 ) than control activity (Fig. 6A1) , and bursting area (0.18 ± 0.07 and 0.24 ± 0.13, before and after perfusion of SubP + riluzole, n = 6 slice preparations, P > 0.05, paired t-test) and duration (0.49 ± 0.03 and 0.41 ± 0.07 s, before and after perfusion of SubP + riluzole, n = 6 slice preparations, P > 0.05, paired t-test) were similar to baseline activity (Fig. 6D) . Thus, INaP does not appear to be a critical current underlying SubP-mediated enhancement of fictive eupnea regularity.
In contrast to INaP-dependent pacemakers, ICAN-dependent pacemaker properties are TRPC channel antagonist sensitive Our data suggest that SubP enhances ICAN via TRPC channels to enhance fictive eupnea. To verify this, we studied the effect of blocking TRPC channels on the SubP-mediated enhancement of synaptically isolated pacemaker bursting activity. As previously shown (Pena & Ramirez, 2004) , SubP enhanced ICAN-dependent pacemaker burst area and regularity ( Fig. 7A1-2 ; and inset, red ⁄ green overlay). We hypothesized that this enhancement was mediated by TRPC channel activation. Here, we additionally found the ICANdependent pacemaker bursting activity was sensitive to TRPC channel antagonists. Indeed, their bursting properties were suppressed within approximately 5 min after adding SKF-96365 (Fig. 7A3) . Longer term (approximately 15 min) SKF-96365 application eliminated ICAN-dependent pacemaker bursting properties altogether, such that suprathreshold current injection initiated action potential spiking, but did not trigger bursting (Fig. 7A4 , n = 7 neurons). Within 5 min of bath application, SKF-96365 inhibited the SubP-mediated increase in bursting irregularity (0.18 ± 0.02 and 0.49 ± 0.09, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.05, paired t-test), and decreased burst area (1 ± 0.45 and 0.24 ± 0.05, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.001, paired t-test) and burst duration (0.74 ± 0.36 and 0.41 ± 0.12 s, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.05, paired t-test) ( Fig. 7B; and inset, black ⁄ red overlay). Burst frequency initially increased after adding SKF-96365 (0.29 ± 0.07 and 0.41 ± 0.07 Hz, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.05, paired t-test) (Fig. 7A3 ), but bursting ceased within approximately 15 min (n = 7 neurons; Fig. 7A1-4 and B) .
In contrast to ICAN-dependent pacemakers, the bursting of synaptically isolated INaP-dependent pacemakers was not dependent on TRPC channels. Indeed, after INaP-dependent pacemakers were exposed to SubP for 20 min (Fig. 8A1-2 , and inset, red ⁄ green overlay), subsequent SKF-96365 application for 15 min did not eliminate their bursting properties (Fig. 8A3) . After pre-exposure to SubP for 20 min (Fig. 8A1-2) , additional co-application of SKF-96365 (15 min) to INaP-dependent pacemakers did not alter their bursting irregularity score (0.16 ± 0.03 and 0.13 ± 0.02, in SubP and in SubP + SKF-96365, respectively, n = 3 slice preparations, P > 0.05, paired t-test), burst area (10 ± 9.61 and 7.45 ± 6.64, in SubP and in SubP + SKF-96365, respectively, n = 3 slice preparations, P > 0.05, paired t-test), burst duration (0.84 ± 0.16 and 1.10 ± 0.31 s, in SubP and in SubP + SKF-96365, respectively, n = 3 slice preparations, P > 0.05, paired t-test) and bursting frequency (0.38 ± 0.06 and 0.35 ± 0.05 Hz, in SubP and in SubP + SKF-96365, respectively, n = 3 slice preparations, P > 0.05, paired t-test) (Fig. 8B) . In contrast, subsequent application of riluzole eliminated their busting properties (Fig. 8A4) , as expected (Peña et al., 2004) . Importantly, bath application of SKF-96365 alone (> 15 min) did not alter INaP-dependent pacemaker bursting in two additional experiments where SubP was not added (data not shown). These data are consistent with our hypothesis that SubP decreases the irregularity of fictive eupneic network activity and synaptically isolated ICAN-dependent pacemaking via TRPC channel activation. Following SubP bath application for 20 min, co-application of FFA, òVRG bursting irregularity, burst area and frequency were similar to control values (ACSF only), while burst duration was reduced (***P < 0.001 paired t-test) (statistical tests were made on raw data).
TRPC channel antagonists block SubP-enhanced inspiratory non-pacemaker bursting during fictive eupnea
We also studied the effect of blocking TRPC channels with SKF-96365 on the SubP-mediated enhancement of non-pacemaker bursting activity during fictive eupnea. During fictive eupnea (Fig. 9A1) we bath-applied 0.1 lm SubP for 20 min (Fig. 9A2) , then subsequently added SKF-96365 (Fig. 9A3 , n = 7 slice preparations). Blocking TRPC channels with SKF-96365 did not eliminate inspiratory nonpacemaker bursting activity (Fig. 9A3 , n = 7 slice preparations), while subsequent co-application of riluzole stopped the network and nonpacemaker bursting activity (Fig. 9A4 , n = 7 slices preparations; in n = 7 ⁄ 7, no rhythmic activity was recorded for > 17 min).
Bath application of 0.1 lm SubP (alone for 20 min) decreased inspiratory non-pacemaker rhythm irregularity (0.28 ± 0.03 and 0.21 ± 0.02, before and after SubP, respectively, n = 7 slice preparations, P < 0.01, paired t-test) and increased burst frequency (0.20 ± 0.11 and 0.36 ± 0.05 Hz, before and after SubP, respectively, n = 7 slice preparations, P < 0.01, paired t-test), but did not significantly alter non-pacemaker burst area (0.47 ± 0.04 and 0.34 ± 0.02, before and after SubP, respectively, n = 7 slice preparations, P > 0.05, paired t-test) or burst duration (0.39 ± 0.08 and 0.29 ± 0.06 s, before and after SubsP, respectively, n = 7 slice preparations, P > 0.05, paired t-test) (Fig. 9B1) . After 20 min in SubP, additional co-application of SKF-96265 increased bursting irregularity (0.21 ± 0.02 and 0.29 ± 0.03, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.05, paired t-test), decreased burst area underlying action potentials (0.34 ± 0.02 and 0.41 ± 0.02, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P < 0.01, paired t-test) without altering burst duration (0.29 ± 0.06 and 0.30 ± 0.08 s, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P > 0.05, paired t-test) or burst frequency (0.36 ± 0.05 and 0.25 ± 0.02 Hz, in SubP and in SubP + SKF-96365, respectively, n = 7 slice preparations, P > 0.05, paired t-test) of inspiratory non-pacemakers (Fig. 9B2) . Furthermore, after co-application of SKF-96365, non-pacemaker bursting irregularity (0.28 ± 0.03 and 0.29 ± 0.03, before and after SubP + SKF-96365, respectively, n = 7 slice preparations, P > 0.05, paired t-test), burst area (0.47 ± 0.03 and 0.41 ± 0.03, before and after SubP + SKF-96365, respectively, n = 7 slice preparations, P > 0.05, paired t-test), burst duration (0.39 ± 0.08 and 0.30 ± 0.08 s, before and after SubP + SKF-96365, respectively, n = 7 slice preparations, P > 0.05, paired t-test) and burst frequency (0.17 ± 0.03 and 0.25 ± 0.02 Hz, before and after SubP + SKF-96365, n = 7 slice preparations, P > 0.05, paired t-test) were similar to control values measured in ACSF alone (Fig. 9B3 , n = 7 slice preparations). In contrast to ICAN pacemakers, non-pacemaker bursting activity continued after blocking TRPC channels. These data also suggest that the SubP-mediated enhancement of non-pacemaker activity is reversed by blocking TRPC channels.
Western Blots reveal the expression of TRPC3 and TRPC7 channels in VRG-islands
Our data indicate that SubP-mediated signaling activates an ICAN, carried by TRPC channels, to improve the regularity of respiratory (D) After preincubation with FFA, rather than enhancing respiratory activity, subsequent SubP application resulted in òVRG rhythmic activity being more irregular, with a reduced burst area, while burst duration and frequency were similar, relative to control values (ACSF only) (*P < 0.05; **P < 0.01, paired t-test) (statistical tests were made on raw data). activity, in vitro. Thus, we made Western blots to identify which TRPC channels are involved in the SubP-mediated improvement of the respiratory rhythm.
Substance P binds to NK1 receptors that are positively coupled to Ga ⁄ q11 protein that activates PLC (Oh et al., 2003) . All TRPC channels are activated by PLC pathways, except TRPC2, which is activated by receptors coupled to Gi ⁄ o proteins that inhibit PLC (Clapham, 2007) ; thus, TRPC2 activity does not underlie the SubPmediated enhancement of respiratory activity.
Qualitative Western blots were made to determine the expression of TRPC1, TRPC3, TRPC4, TRPC5, TRPC6 and TRPC7 channels in VRG-islands dissected from 600-lm brain slices, after mapping the extent of the pre-BötC ⁄ VRG region of rhythmic bursting activity with a population electrode on the surface of the slices from postnatal day 8 to 10 mice ( Fig. 10A and B) . These Western blots also included cortical and cerebellar tissues, isolated from the same mice, as a positive control for the antibodies used. Western blots revealed the expression of NK1 receptors in VRG-islands (Fig. 10C , n = 3 VRGislands 1-3). TRPC1 (n = 5) channels were detected in the cortex and cerebellum tissue samples, but never in the VRG-islands (Fig. 10D) . TRPC3 channels were found in all of the cortical, cerebellar and VRGisland tissues tested (Fig. 10D , n = 5). TRPC4 (n = 3) channels were detected in the cortex and cerebellum tissue samples, but not in the VRG-islands (Fig. 10D) . TRPC5 (n = 5) and TRPC6 channels (n = 3) were expressed in all of the cortical tissue samples, but were not expressed in the cerebellum or VRG-islands (Fig. 10D) . TRPC7 channels were not expressed in the cortex but were expressed in the cerebellum and VRG-islands (Fig. 10D , n = 5).
Other groups have proposed that ICAN-dependent bursting properties may be mediated by TRPM4 (Crowder et al., 2007; Mironov, 2008) . Our data suggest that TRPM4 is expressed in the cortex (n = 2) and cerebellum (n = 2), but TRPM4 is either very weakly expressed or not expressed in VRG-island preparations ( Fig. 10E ; n = 4). In summary, among TRPC channels, only TRPC3 and TRPC7 were found to be expressed in the VRG-islands where NK1 receptors are also expressed.
Discussion
SubP is known to improve the regularity of the respiratory rhythm, in vitro (Pena & Ramirez, 2004) . Here, we demonstrate that SubP signaling leads to activation of TRPC3 and ⁄ or TRPC7 (TRPC3 ⁄ 7) channels to improve respiratory rhythm regularity at the network, non-pacemaker and ICAN pacemaker levels. These effects and ICAN pacemaking are blocked by TRPC3 ⁄ 7 channel antagonists, either SKF-96365 or FFA (Figs 3 and 4) .
Our data show that SubP, via NK1 receptors, selectively increases ICAN-dependent intrinsic bursting mechanisms to enhance fictive eupneic regularity (Fig. 7) . Indeed, blocking ICAN with FFA, reverses or prevents SubP-mediated enhancement of fictive eupneic regularity (Figs 4 and 5) . In contrast, blocking INaP with riluzole did not reverse SubP-mediated enhancement of fictive eupnea regularity (Fig. 6) . (Fig. 7B, 1) , òVRG rhythmic activity is less irregular and has a higher frequency, while burst area and burst duration were similar to control values (ACSF only, Fig. 7A , 1, *P < 0.05; **P < 0.01, paired t-test) (statistical tests were made on raw data). SubP, subsequent co-application of SKF-96365 for 5 min initially leads to an increase in burst irregularity and decrease in burst area, while burst duration is initially the same as in SubP, and burst frequency is increased prior to reducing then eliminating bursting (*P < 0.05; ***P < 0.001, paired t-test) (statistical tests were made on raw data). Combined bath application of FFA and riluzole eliminates respiratory rhythm bursting mechanisms (Peña et al., 2004) . Here, we show that SKF-96365 also blocks ICAN-dependent intrinsic bursting and sensitizes the VRG population rhythm to riluzole. In contrast, SKF-96365 does not block INaP-dependent intrinsic bursting properties nor does SKF-96365 reverse the SubP-mediated Fig. 9 . SubP enhancement of inspiratory non-pacemaker activity is reversed by SKF-96365. (A1) Fictive eupneic activity (òVRG) and inspiratory non-pacemaker neuron recorded in control conditions (ACSF) and after (A2) bath application of SubP (20 min). (A3) In the presence of SubP, subsequent bath co-application of SKF-96365 does not eliminate òVRG and inspiratory non-pacemaker bursting properties, while (A4) subsequent additional co-application of riluzole eliminates inspiratory non-pacemaker rhythmic bursting. (B1) SubP application decreases inspiratory non-pacemaker rhythm irregularity and increases burst frequency but does not significantly alter burst area or burst duration (*P < 0.05, paired t-test). (B2) After 20 min in SubP, subsequent co-application of SKF-96365 increased bursting irregularity, decreased burst area underlying action potentials and decreased burst frequency, without altering burst duration of inspiratory non-pacemakers (*P < 0.05, paired t-test). (B3) Following bath application of SubP for 20 min and subsequent co-application of SKF-96365, non-pacemaker bursting irregularity, burst area, burst duration and burst frequency were similar to control values measured in ACSF alone (statistical tests were made on raw data). enhancement of INaP-dependent pacemaker bursting (Fig. 9) (Pena & Ramirez, 2004) .
SubP is known to activate TRPC3 channels (Oh et al., 2003) . Here, we demonstrate that in VRG-islands, TRPC3 and TRPC7 channels are expressed (Fig. 10) . Thus, we propose that ICAN-dependent endogenous bursting is mediated via TRPC3 ⁄ 7 channels, as we reverse the effects of SubP modulation of ICAN-dependent bursting properties with TRPC3 ⁄ 7 channel antagonists. Currently, there are no commer- òVRG activity recorded from the VRG-island after its isolation from the rest of the medullary slice, in control conditions (ACSF). (C) NK1 receptors (10 lg total protein, lanes 1-3) and (D) TRPC1 channels are expressed in the cortex, but not in the cerebellum or VRG-island preparations (15 lg total protein). TRPC3 channels are expressed in all the VRG-islands tested (15 lg total protein, lanes 1-3). TRPC4 channels are expressed in the cortex and cerebellum but not the VRG-islands, (15 lg total protein), whereas TRPC5 channels (15 lg total protein) and TRPC6 channels preparations (15 lg total protein) are expressed in the cortex but not in the cerebellum or VRG-islands. TRPC7 channels are expressed in the cerebellum and VRG-islands (15 lg total protein). (E) TRPM4 channels were detected in the cortex (10 lg total protein, lanes 1 and 2) and cerebellum (10 lg total protein, lanes 1 and 2) but did not appear to be expressed in the VRG-island (VRG-island preparations; 10 lg total protein, lanes 1 and 3; 50 lg total protein, lanes 2 and 4). cially available selective TRPC3 or TRPC7 channel antagonists to precisely distinguish between the contribution of these channels to the respiratory rhythm regularity.
Rhythmic activity in the VRG has been previously hypothesized to depend in part on TRPM4 ⁄ 5 (Crowder et al., 2007; Mironov, 2008) . To our knowledge, SubP is not known to activate TRPM channels and we were unable to detect TRPM4 protein expression in Western blots made from VRG-island preparations. Thus, either (i) TRPM4 proteins are not expressed in the VRG-islands in CD-1 mice (age P8); (ii) TRPM4 expression is very low in the VRG (we did not detect TRPM4 at 10 or 50 lg ⁄ mL total protein); or (iii) the TRPM4 antibodies we used were non-competent. As the antibody we used appears to recognize TRPM4 expression in the cortex and cerebellum, but not the VRG-island (at 10 lg ⁄ mL total protein), the third possibility is unlikely.
It was proposed that SubP modulates a TTX resistant (TTX-R) background sodium current to enhance respiratory pacemaker bursting properties (Pena & Ramirez, 2004) . We also previously found that a reduction in background sodium currents results in irregular inspiratory network and pacemaker bursting (Tryba & Ramirez, 2004b; Chevalier et al., 2008) . Indeed, SubP signaling activates TRPC3 channels, which largely carry a TTX-R sodium current (Zhou et al., 2008) , and here our data suggest that SubP modulation of TRPC3 ⁄ 7 channel currents enhances respiratory network and pacemaker bursting regularity. Canonical transient receptor proteins, such as TRPC channels, depend on an increase in intracellular calcium for full activation, which would typically be augmented during an ongoing burst of action potentials (Oh et al., 2003; Clapham, 2007) . It should be noted that TRPC channels are additionally associated with intracellular calcium oscillations (Rey et al., 2006) and our study suggests TRPC3 ⁄ 7 channels are well suited to underlie and ⁄ or amplify intrinsic bursting properties to alter the regularity of breathing activity.
A dysregulation of TRPC3 channels has been implicated in Rett syndrome (Deguchi et al., 2000) , in which an irregular breathing rhythmogenesis is typical (Viemari et al., 2005) . Our data suggest that a dysfunction in TRPC3 ⁄ 7 channel activation may result in irregular breathing activity. We demonstrated that activation of TRPC3 ⁄ 7 by synaptically released SubP signaling improves the respiratory rhythm regularity. These data do not exclude the possible contribution of other neuromodulators that can activate TRPC channels, such as brain-derived neurotrophic factor (BDNF) (Bouvier et al., 2008) . Dysregulation of BDNF signaling has been hypothesized to underlie the functional and structural consequences of MeCP2 mutations in Rett syndrome .
